Steroid Injection in De Quervain Tenosynovitis

De Quervain Disease Clinical Trial

Official title:

Effectiveness of Steroid Injection in Treating Pain in De Quervain Tenosynovitis

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05261737
• Other study ID #: 2018/00787
• Status: Recruiting
• Start date: March 14, 2019
• Est. completion date: December 2022

Study information

• Verified date: February 2022
• Source: National University Hospital, Singapore
• Contact: Vanessa Wan
• Phone: 67728237
• Email: vanessa_wan[@]nuhs.edu.sg
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This study is carried out to find out the degree of pain relief achieved with standard treatment as steroid injection as well as its time to onset. It will recruit 50 subjects over a period of 18 months.

Description:

The aim of the study is determine how effective these injections are and when will the patient start feeling relief of his/her symptoms.The aim of the study is not to change the current practice, but provide hand surgeons enough data to clarify their patients the expected outcomes and onset timing of the treatment performed.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: December 2022
• Est. primary completion date: December 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• >21 years old

Exclusion Criteria:

• Pregnancy

Related Conditions & MeSH terms

• De Quervain Disease
• Tenosynovitis

Intervention

Procedure:
• Corticosteroid Injection
Steroid injection effectiveness will be determined by relief of pain scored by patient using Visual Analogue Scale (VAS). Data will be collected during clinic visit and contacting patients in a determined protocol for the following 6 weeks after steroid injection.After approval of the study, data will collected from participants over a period of 6 weeks follow up; the whole study will be conducted over a total of 2 years.Since the study will not conduct any further test to participants and follow up regimen will only state pain related to the specific condition (De Quervain tenosynovitis) and quick-DASH score, it will not result in any anticipated/unanticipated incidental findings, therefore participants will not be recontacted.

Locations

Country	Name	City	State
Singapore	National University Hospital	Singapore

Sponsors (1)

Lead Sponsor	Collaborator
National University Hospital, Singapore

Country where clinical trial is conducted

Singapore, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Determine efficacy of steroid injection	a single steroid injection over first dorsal compartment for patients diagnosed with de Quervain tenosynovitis will make effect within 7 days from injection, relieving pain to less or equal than 1 in Visual Analogue Scale (VAS)	7 days